These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 30690341

  • 1. Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack.
    Yang X, Huang Q, Yang H, Liu S, Chen B, Liu T, Yang J, Yao H, Lin S, Chen X, Zhuang H, Long Y, Gao C.
    Mult Scler Relat Disord; 2019 Apr; 29():94-99. PubMed ID: 30690341
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: Retrospective research of clinical practice, biomarkers, and pathology.
    Lin PH, Yao HY, Huang L, Fu CC, Yao XL, Lian C, Zhang SF, Lai WD, Lin GY, Liao S, Yang J, Mao ZF, Liu D, Long BY, Yue JJ, Gao C, Long YM.
    CNS Neurosci Ther; 2024 Sep; 30(9):e70042. PubMed ID: 39279053
    [Abstract] [Full Text] [Related]

  • 4. CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD.
    Kleerekooper I, Herbert MK, Kuiperij HB, Sato DK, Fujihara K, Callegaro D, Marignier R, Saiz A, Senel M, Tumani H, De Jong BA, Trip SA, Nakashima I, Verbeek MM, Petzold A.
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):605-611. PubMed ID: 32217788
    [Abstract] [Full Text] [Related]

  • 5. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R, Misu T, Takahashi T, Sato S, Fujihara K, Itoyama Y.
    Neurology; 2010 Jul 20; 75(3):208-16. PubMed ID: 20644148
    [Abstract] [Full Text] [Related]

  • 6. Comparison of clinical and radiological characteristics in autoimmune GFAP astrocytopathy, MOGAD and AQP4-IgG+ NMOSD mimicking intracranial infection as the initial manifestation.
    Xiao J, Zhang SQ, Chen X, Tang Y, Chen M, Shang K, Deng G, Qin C, Tian DS.
    Mult Scler Relat Disord; 2022 Oct 20; 66():104057. PubMed ID: 35870369
    [Abstract] [Full Text] [Related]

  • 7. Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
    Masaki K, Suzuki SO, Matsushita T, Yonekawa T, Matsuoka T, Isobe N, Motomura K, Wu XM, Tabira T, Iwaki T, Kira J.
    Acta Neuropathol; 2012 Jun 20; 123(6):887-900. PubMed ID: 22438105
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical characteristics, immunological alteration and distinction of MOG-IgG-associated disorders and GFAP-IgG-associated disorders.
    Zeng R, He L, Kuang Z, Jian Y, Qiu M, Liu Y, Hu M, Ye Y, Wu L.
    J Neuroimmunol; 2024 Aug 15; 393():578398. PubMed ID: 39002186
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease.
    Kim H, Lee EJ, Kim S, Choi LK, Kim K, Kim HW, Kim KK, Lim YM.
    Neurol Neuroimmunol Neuroinflamm; 2020 May 15; 7(3):. PubMed ID: 32184342
    [Abstract] [Full Text] [Related]

  • 14. Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy.
    Ding J, Ren K, Wu J, Li H, Sun T, Yan Y, Guo J.
    J Neurol; 2020 Sep 15; 267(9):2589-2593. PubMed ID: 32378036
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Presenting with Slowly Progressive Myelitis and Longitudinally Extensive Spinal Cord Lesions.
    Kudo T, Kimura A, Higashida K, Yamada M, Hayashi Y, Shimohata T.
    Intern Med; 2020 Nov 01; 59(21):2777-2781. PubMed ID: 32669494
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker.
    Misu T, Takano R, Fujihara K, Takahashi T, Sato S, Itoyama Y.
    J Neurol Neurosurg Psychiatry; 2009 May 01; 80(5):575-7. PubMed ID: 19372295
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.